Rising global burdens of urinary tract infections, kidney stones, glomerular disorders, and urological malignancies—paired with expanding geriatric demographics and earlier clinical detection—are driving steady expansion across the Hematuria Treatment Market, projected to grow from USD 1.192 billion in 2025 to USD 1.556 billion by 2035 at a 2.7% CAGR. Hematuria treatment...